GLI3 and cancer: Differential gene expression analysis identified that inflammation‐responsive transcription factors, such as CCL3L1, characterized patients with relapse T‐ALL, along with deregulation of several key cancer regulators such as FAT3 [11], CFTR [12] and GLI3 [13] (Figure 1D, Figure SF1A).